SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-17-342556
Filing Date
2017-11-14
Accepted
2017-11-14 16:07:45
Documents
6
Period of Report
2017-11-14

Document Format Files

Seq Description Document Type Size
1 FORM 6-K d483371d6k.htm 6-K 12506
2 EX-99.1 d483371dex991.htm EX-99.1 380977
3 EX-99.2 d483371dex992.htm EX-99.2 192566
4 EX-99.3 d483371dex993.htm EX-99.3 10282
5 EX-99.4 d483371dex994.htm EX-99.4 10278
6 GRAPHIC g483371g61j56.jpg GRAPHIC 2231
  Complete submission text file 0001193125-17-342556.txt   610828
Mailing Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8
Business Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8 250-708-4272
Aurinia Pharmaceuticals Inc. (Filer) CIK: 0001600620 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36421 | Film No.: 171201527
SIC: 2834 Pharmaceutical Preparations